GlycoMimetics, Inc. Profile Avatar - Palmy Investing

GlycoMimetics, Inc.

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inh…

Biotechnology
US, Rockville [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of GLYC's Analysis
CIK: 1253689 CUSIP: 38000Q102 ISIN: US38000Q1022 LEI: - UEI: -
Secondary Listings
GLYC has no secondary listings inside our databases.